Biotecnología

Biotecnología

Genezen Appoints Jeff Whitmore as Chief Commercial Officer
30/11/2022 - Whitmore has 25 years’ experience in biotechnology.
Oxford Biomedica Appoints Dr. Frank Mathias as CEO and Board Director
23/11/2022 - Mathias previously served as CEO of Rentschler Biopharma SE, which he successfully developed into a leading global, full-service CDMO.
RotaTeq
23/11/2022 - RotaTeq is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by typesG1, G2, G3, G4, and G9.
GVB Biopharma Opens New Distribution Facility in the Netherlands
23/11/2022 - Will support GVB’s growing business in Europe, the Middle East, and Africa (EMEA).
Sunshine Biopharma Enters LNP Alliance for mRNA Macromolecule
23/11/2022 - To conduct in vivo studies to advance the development of Sunshine Biopharma’s mRNA-based anticancer macromolecule, K1.1.
Rentschler Biopharma Appoints Christiane Bardroff as COO
17/11/2022 - Bardroff will head clinical and commercial manufacturing, engineering and technology operations, as well as production automation.
WuXi Vaccines Establishes New Vaccines CDMO Facility in China
16/11/2022 - The 8,500-square-meter facility includes multiple 250L, 500L and 1000L single-use bioreactors as well as sterile drug-product manufacturing lines.
Fujifilm Diosynth Biotechnologies Expands Partnership with NC State
16/11/2022 - To focus on research and facility design to support Fujifilm’s goal to achieve net-zero carbon emissions by 2030 for its new $2 billion site in Holly Springs.
BioNTech Acquires Novartis Mfg. Site in Singapore for mRNA Production
15/11/2022 - Establishes regional manufacturing capacities to support pipeline of mRNA-based vaccines and therapeutics across Asia Pacific region.
Harbour BioMed Establishes Wholly-Owned Subsidiary, Nona Biosciences
15/11/2022 - Subsidiary will make Harbour’s technologies broadly accessible to biotechnology and biopharma companies and academic institutions.
Lantheus and POINT Biopharma Enter Strategic Collaboration and Exclusive License Agreement
15/11/2022 - Expands Lantheus’ portfolio with license of exclusive worldwide rights, excluding certain territories, to two late-stage therapeutic agents.
Vaccines and Related Biological Products Advisory Committee June 14-15, 2022 Meeting Announcement - 06/14/2022
15/11/2022 - This is the CBER Vaccines and Related Biological Products Advisory Committee June 14-15, 2022 Meeting Announcement.
Emergent BioSolutions 3Q Results
15/11/2022 - Completes acquisition of worldwide rights to TEMBEXA; Anthrax vaccines revenue increases $8.6 million in the quarter.
Wheeler Bio, CRB Unveil New Oklahoma City Manufacturing Facility
10/11/2022 - 35,000-square-foot facility for clinical drug substance manufacturing of antibodies and recombinant proteins.
GARDASIL 9
10/11/2022 - Product approval information for Human Papillomavirus 9-valent Vaccine, Recombinant also known as Gardasil 9.
VARIVAX (refrigerated and frozen formulations)
08/11/2022 - Product approval information for Varicella Virus Vaccine Live also known as Varivax.
BIOVECTRA Launches Single-use Biologics Fermentation Suite
07/11/2022 - To offer single-use, microbial fermentation at the 1,000 L scale.
TFF Pharmaceuticals Enters Collaboration with Aptar Pharma
04/11/2022 - Aims to develop and test the administration of dry powder vaccines.
Flublok Quadrivalent
03/11/2022 - Flublok Quadrivalent is a vaccine indicated for active immunization against disease caused by influenza A subtype viruses and influenza type B viruses contained in the vaccine. Flublok Quadrivalent...
Moderna COVID-19 Vaccines
03/11/2022 - Information about Spikevax, Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine, Bivalent. Updated COVID-19 vaccine boosters are now FDA-authorized.